Validating and Evaluating the Pain Medicine Digital Workflow Algorithm (PGS 1.0)
Prospective Validation and Performance Evaluation of the Algorithm of the Pain Medicine Digital Workflow (PGS 1.0)
- Chronic Pain
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- PG Medical Systems Ltd.
- Enrolment target
- 200
- Started
- 17 September 2025
- Main results due
- December 2026
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Ages 18 years to 80 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Patient is willing and capable of providing Informed Consent. * Pain persisting for at least 1 month. Exclusion Criteria: None
What this study is about
In the sponsor’s own words, from the registry.
This is a prospective, non-randomized, double blind, single center, single arm, validation study, to evaluate the performance of PGS 1.0 algorithm in analyzing pain specific symptoms and medical history data of pain patients referred to a pain expert consultation.
Study sites(1)
Pain Medicine Institute, Rambam Health Care Campus
Haifa, Israel
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07195162. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me